Tempo differito
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,54 CAD | +0,65% | +4,76% | -13,97% |
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11/05/11 |
Kirk Look
DFI | Director of Finance/CFO | - | 01/04/03 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/20 |
Jon Patton
IRC | Investor Relations Contact | - | 01/08/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 07/09/22 |
Patricia Andrews
BRD | Director/Board Member | 66 | 09/01 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 08/06/15 |
James Parsons
BRD | Director/Board Member | 58 | 16/06/22 |
Angela Holtham
BRD | Director/Board Member | 73 | 18/06/14 |
Matthew Coffey
CEO | Chief Executive Officer | - | 11/05/11 |
Wayne Pisano
CHM | Chairman | 69 | 09/05/13 |
Deborah Brown
BRD | Director/Board Member | - | 02/11/17 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 75 419 768 | 72 478 872 ( 96,10 %) | 0 | 96,10 % |
Coordinate società
Oncolytics Biotech, Inc.
322–11th Avenue SW Suite 804
T2R 0C5, Calgary
+
http://www.oncolyticsbiotech.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-13,97% | 83,96 Mln | |
-0,45% | 42,19 Mrd | |
+44,30% | 40,15 Mrd | |
-6,20% | 28,31 Mrd | |
+5,46% | 24,63 Mrd | |
-23,61% | 18,2 Mrd | |
+26,44% | 12,01 Mrd | |
-3,75% | 11,76 Mrd | |
+14,61% | 10,4 Mrd | |
-3,82% | 9,94 Mrd |
- Borsa valori
- Azioni
- Azione ONC
- Società Oncolytics Biotech Inc.